Congress Rakes In Millions From Drugmakers
Members of Congress received almost $4 million from pharmaceutical manufacturers and their trade groups in the first half of 2019.
September 20, 2019
Members of Congress received almost $4 million from pharmaceutical manufacturers and their trade groups in the first half of 2019.
According to a new poll, even the U.S. federal government is more well-liked by Americans than the pharmaceutical industry.
All eyes were on Oklahoma last week, when the first case in a flood of litigation against opioid drug manufacturers began Tuesday.
Headlines proclaimed a potential game changer in treating cardiovascular disease—Vascepa—and company shares quickly soared, but the study behind the claim remains a mystery.